SANA Sana Biotechnology Inc
Price (delayed)
$1.63
Market cap
$366.79M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.16
Enterprise value
$329.59M
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. Sana shares a vision of repairing and controlling genes, replacing missing or damaged cells, and
Highlights
The EPS is up by 21% year-on-year and by 17% since the previous quarter
The net income is up by 13% since the previous quarter and by 6% year-on-year
SANA's quick ratio is down by 20% from the previous quarter but it is up by 6% YoY
The equity has contracted by 14% from the previous quarter and by 13% YoY
Key stats
What are the main financial stats of SANA
Market
Valuations
Earnings
Shares outstanding
225.02M
Market cap
$366.79M
Enterprise value
$329.59M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.45
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$272.72M
Net income
-$266.76M
EBIT
-$266.76M
EBITDA
-$239.69M
Free cash flow
-$256.58M
Per share
Balance sheet
Liquidity
EPS
-$1.16
EPS diluted
-$1.16
Free cash flow per share
-$1.11
Book value per share
$1.12
Revenue per share
$0
TBVPS
$1.3
Total assets
$501.02M
Total liabilities
$250.52M
Debt
$94.2M
Equity
$250.5M
Working capital
$115.38M
Debt to equity
0.38
Current ratio
3.54
Quick ratio
3.44
Net debt/EBITDA
0.16
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-45.2%
Return on equity
-84.8%
Return on invested capital
-90.6%
Return on capital employed
-58.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SANA stock price
How has the Sana Biotechnology stock price performed over time
Intraday
8.67%
1 week
-9.94%
1 month
-37.55%
1 year
-81.52%
YTD
0%
QTD
-2.98%
Financial performance
How have Sana Biotechnology's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$272.72M
Net income
-$266.76M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 13% from the previous quarter and by 7% YoY
The net income is up by 13% since the previous quarter and by 6% year-on-year
Growth
What is Sana Biotechnology's growth rate over time
Valuation
What is Sana Biotechnology stock price valuation
P/E
N/A
P/B
1.45
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 21% year-on-year and by 17% since the previous quarter
SANA's P/B is 62% below its last 4 quarters average of 3.5 and 58% below its 5-year quarterly average of 3.2
The equity has contracted by 14% from the previous quarter and by 13% YoY
Efficiency
How efficient is Sana Biotechnology business performance
The return on equity has grown by 10% since the previous quarter but it has declined by 7% year-on-year
Sana Biotechnology's ROA has increased by 10% from the previous quarter but it has decreased by 6% YoY
The company's return on invested capital rose by 9% QoQ but it fell by 2.1% YoY
Dividends
What is SANA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SANA.
Financial health
How did Sana Biotechnology financials performed over time
The company's total assets is 100% higher than its total liabilities
The current ratio is down by 21% from the previous quarter but it is up by 7% YoY
SANA's quick ratio is down by 20% from the previous quarter but it is up by 6% YoY
SANA's debt is 62% smaller than its equity
The debt to equity rose by 15% since the previous quarter and by 6% year-on-year
The equity has contracted by 14% from the previous quarter and by 13% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.